{
    "organizations": [],
    "uuid": "661d03130148a7ac93408fb4363d5516ed1748e1",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cancer-genetics-unique-tissue-of-o/brief-cancer-genetics-unique-tissue-of-origin-test-clearance-idUSASC09VWP",
    "ord_in_thread": 0,
    "title": "BRIEF-Cancer Genetics’ Unique Tissue Of Origin Test (Too®) Receives Special FDA 510(K) Clearance",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 16 (Reuters) - Cancer Genetics Inc:\n* CANCER GENETICS’ UNIQUE TISSUE OF ORIGIN TEST (TOO®) RECEIVES SPECIAL FDA 510(K) CLEARANCE\n* CANCER GENETICS’ UNIQUE TISSUE OF ORIGIN TEST (TOO®) RECEIVES SPECIAL FDA 510(K) CLEARANCE Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-04-16T19:31:00.000+03:00",
    "crawled": "2018-04-17T12:33:48.005+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "cancer",
        "genetics",
        "inc",
        "cancer",
        "genetics",
        "unique",
        "tissue",
        "origin",
        "test",
        "receives",
        "special",
        "fda",
        "k",
        "clearance",
        "cancer",
        "genetics",
        "unique",
        "tissue",
        "origin",
        "test",
        "receives",
        "special",
        "fda",
        "k",
        "clearance",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}